Experience and Reliability
from your First Gram
For over 15 years, Avecia has used technical expertise and unmatched experience in oligonucleotide production to provide exceptional service. Our commitment to flexible solutions and innovative ideas drives us to continue to meet and exceed the needs of our customers and the oligonucleotide therapeutic market.
New for 2013: Avecia has grown with the acquisition of Girindus America’s CMO business. We are pleased to provide our valuable customers with an expanded oligo service portfolio, additional security of supply with a second manufacturing site, as well as radiolabeling and small molecule capabilities! Explore our website to learn more about these new programs, and check back regularly for more updates.For high quality, flexible and friendly service, count on Avecia, a Nitto Denko Company.